In a mouse model of ischemic stroke, minocycline treatment (1–50 mg/kg/day of minocycline for 3–14 consecutive days) inhibits NLRP3 expression in microglia confirmed by reduced number of NLRP3+ IBA-1+ cells. Here, NLRP3 is linked to ischemic stroke.